Development by UCLA-led research team works to keep blood sugar at normal levels
UCLA bioengineers and their colleagues have developed a new type of insulin that could help prevent hypoglycemia in people who use the drug to manage diabetes.
The treatment is being evaluated for potential clinical trials and, if successful, could change diabetes care. The study was published in the Proceedings of the National Academy of Sciences.
Insulin is a hormone naturally produced in the pancreas. It helps the body regulate glucose, which is consumed through food and provides the body with energy.
Diabetes occurs when a person’s body does not naturally produce insulin (Type 1 diabetes), or does not efficiently use the insulin that is produced (Type 2). In either case, a regular dosage of insulin is prescribed to manage the disease, which affects more than 400 million people worldwide.
Generally, people who need to use insulin monitor their blood sugar levels with a glucose meter or continuous glucose monitoring system and then calculate their insulin dose accordingly. In addition, a regular carbohydrate intake is important to keep the blood sugar levels normal. Both of these requirements are necessarily subject to human error, which can have potentially devastating consequences.
An overdose of insulin can cause hypoglycemia, when blood sugar is too low. That could lead to seizures, coma, and in extreme cases, death.
As a safety check, the UCLA-led team has developed a type of “smart” insulin, called i-insulin, that can prevent blood sugar levels from dipping too low.
Inside the body, insulin acts as a “key” to help glucose get into cells from the bloodstream. When insulin attaches to a cell’s surface, it activates a protein inside the cell, called glucose transporter, which then makes its way to the cell’s surface. This molecule then brings the surrounding glucose from the blood into the cell.
The research team added an additional molecule to insulin to create the new smart insulin. This added molecule, called a glucose transporter inhibitor, chemically blocks the glucose transporter molecule that has come to the surface. Its presence doesn’t block all glucose from entering, nor does it permanently block the transporter molecules. Instead, it’s part of a dynamic process that depends on how many inhibitor and glucose molecules are present.
“Our new i-insulin works like a ‘smart’ key,” said the study’s principal investigator Zhen Gu, a professor of bioengineering at the UCLA Samueli School of Engineering. “The insulin lets glucose get into the cell, but the added inhibitor molecule prevents too much from going in when blood sugar is normal. This keeps blood sugar at normal levels and reduces the risk of hypoglycemia.”
“This i-insulin can also rapidly respond to high glucose levels,” added Jinqiang Wang, the study’s co-lead author and a postdoctoral researcher in Gu’s research group. “For example, after a meal, when glucose levels climb, the insulin level in the bloodstream also quickly increases, which helps normalize the glucose level.”
The UCLA-led research team tested the smart insulin on mice with Type 1 diabetes. The i-insulin controlled glucose levels within the normal range for up to 10 hours after a first injection. A second injection three hours later extended the protection from hypoglycemia.
“The next step is to further evaluate the long-term biocompatibility of the modified insulin system in an animal model before determining whether to move to clinical trials,” said co-author Dr. John Buse, a professor and director of the Diabetes Care Center at the University of North Carolina School of Medicine. “The vision, if realized, would be one of the most exciting advances in diabetes care.”
“The new insulin has the potential to be optimized for response times and how long it could last in the body before another dose would be required,” Gu said. “And it could be delivered in other methods, such as a skin patch with tiny needles, or in pills.”
The Latest on: Diabetes
via Google News
The Latest on: Diabetes
- Acupuncture may help ward off diabetes, study findson August 2, 2022 at 3:54 pm
Stress can lead to Type-2 diabetes. This is where acupuncture comes in, according to new research, which claims the therapy is more than just using needles.
- Acupuncture therapy may be a useful tool to ward off type 2 diabeteson August 2, 2022 at 1:44 pm
It's been used for thousands of years to treat a variety of illnesses -; and now acupuncture could also help fight one of the 21st century's biggest health challenges.
- Lowering BP Boosts CV Health Irrespective of Diabetes: Meta-analysison August 2, 2022 at 9:52 am
Strategies for BP reduction should be guided by cardiovascular risk and not by whether a patient has diabetes, a researcher says.
- What Is Type 3 Diabetes? Researchers Identify Malnutrition-Related Disorder That Affects Millionson August 2, 2022 at 3:40 am
The aim of the researchers was to find the metabolic characteristics of the individuals with this disease to prove that "low BMI" diabetes is a distinct form of diabetes.
- Could acupuncture help ward off diabetes?on August 2, 2022 at 1:09 am
It's been used for thousands of years to treat a variety of illnesses—and now acupuncture could also help fight one of the 21st century's biggest health challenges.
- 7 Best Glucose Meters That Make Managing Diabetes a Tiny Bit Easieron August 1, 2022 at 1:11 pm
Blood glucose meters should be accurate and easy to find. Here, experts and reviewers share their top glucometer recommendations.
- Researchers Identify a Baffling New Type of Diabetes That Affects Millionson August 1, 2022 at 8:13 am
A new study investigates a mysterious form of diabetes. Malnutrition-related diabetes is a mysterious form of diabetes that affects tens of millions of individuals in sub-Saharan Africa and Asia.
- Type 1 diabetes linked to higher risk of mental health problems in patients and familyon August 1, 2022 at 8:02 am
Both children with type 1 diabetes and their closest family members are at increased risk of mental health problems compared with those without the disease, according to a large study by researchers ...
- Study unravels secrets of ‘mysterious’ form of diabetes that affects millionson August 1, 2022 at 2:13 am
New findings suggest people with this rare type of diabetes have a ‘very profound’ defect in insulin secretion ...
- A Diabetes Drug Could Protect Against Alzheimer’son August 1, 2022 at 1:45 am
Target protein for diabetes drug linked to a lower risk of Alzheimer's disease According to a study from the Karolinska Institutet in Sweden that was published in the journal Neurology, mechanisms ...
via Bing News